Community Health Systems Reports 9.8% Revenue Decline in Q2 2026

Community Health Systems, Inc. reported a significant decline in financial performance for the second quarter of 2026, with net operating revenues of $2.825 billion, down 9.8% from $3.133 billion in the same period of 2025. For the first half of 2026, revenues also decreased to $5.790 billion from $6.292 billion year-over-year. The company attributed this decline to a combination of reduced patient admissions and the impact of divestitures, which resulted in a decrease of $373 million in non-same-store revenues for the quarter. Net income for the second quarter was $104 million, a sharp drop from $320 million in the prior year, while net income for the first half fell to $79 million from $345 million.

Operationally, Community Health Systems experienced an 11.4% decrease in consolidated inpatient admissions and an 11.7% drop in adjusted admissions for the second quarter compared to the previous year. However, on a same-store basis, inpatient admissions increased by 1.9%, indicating some recovery in facilities that remained operational throughout both periods. The company also reported a notable increase in charity care services, with an estimated value of $519 million for the second quarter, compared to $334 million in the same quarter of 2025.

Strategically, the company engaged in both acquisitions and divestitures during the first half of 2026. It spent approximately $53 million to acquire operating assets from physician practices and clinics, while divesting several hospitals, including four in Arkansas and three in Pennsylvania, which collectively generated about $1.6 billion in annual revenues prior to their sale. The divestitures yielded approximately $1.2 billion in net proceeds, which the company plans to use for general corporate purposes, including potential debt repayments.

In terms of financial health, Community Health Systems reported total assets of $12.177 billion as of June 30, 2026, down from $13.204 billion at the end of 2025. The company’s long-term debt decreased to $9.552 billion from $10.380 billion, reflecting its ongoing efforts to manage debt levels amid challenging market conditions. The company also noted a net cash outflow of $209 million from operating activities for the first half of 2026, a stark contrast to the $208 million inflow reported in the same period of 2025. Looking ahead, the company anticipates continued challenges due to regulatory changes and economic pressures, particularly concerning Medicaid and Medicare reimbursement rates, which may further impact its financial results.